Massively explains Warhammer Online to the dedicated WoW player

AOL Money & Finance

Option Update: Genentech volatility flat at 29 into EPS

Genentech (NYSE: DNA), the manufacture of Avastin, a treatment for patients with advanced lung, colon, or breast cancer, is scheduled to report Q2 EPS on July 14. DNA August option implied volatility of 29 is near its 26-week average according to Track Data, suggesting non-directional price movement.

Financial Select Sector-XLF overall volatility at 42; 26-week average is 34

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Related Posts

Symbol Lookup
IndexesChangePrice
DJIA+494.138,046.42
NASDAQ+68.231,384.35
S&P 500+47.59800.03

Last updated: November 23, 2008: 02:15 PM

BloggingStocks Exclusives

Hot Stocks

BloggingStocks Featured Video

TheFlyOnTheWall.com Headlines

WalletPop Headlines

AOL Business News

Latest from BloggingBuyouts

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance